Substance,Type of TRV,TRV Value,Study Details,"Threshold/
Non-threshold
Endpoint",TRV Derivation Method,"Critical
Effect(s)","Carcinogenicity
Classification",Source
"Dichlorobenzene,
1,4-",Oral TDI,"1.1E-01
mg/kg -day
BW","Study Type: chronic
Species: rats and mice
Mode of Administration: gavage,
corn oil
Exposure Regime: male rats: 0, 150,
or 300 mg/kg -day, 5 days/week; female
BW
rats and male and female mice: 0, 300,
or 600 mg/kg -day, 5 days/week
BW
Duration: 103 weeks
Uncertainty Factors: 1000 (10 for
intraspecies variability, 10 for interspecies
variability, and 10 for use of LOAEL vs
NOAEL)","LOAEL =
150 mg/kg -day
BW","LOAEL adjusted for
continuous exposure
LOAEL =
adj
107 mg/kg -day
BW
TDI = LOAEL /UF
adj","Nephrotoxicity
(renal tubular
degeneration
and atrophy)","CEPA: Group III
possibly
carcinogenic
to humans
(EC and HC, 1993d)
IARC: Group 2B
possibly
carcinogenic
to humans
(IARC, 1999b)
US EPA IRIS:
not assessed","HC, 1996
(based on
NTP, 1987)"
"Dichlorobenzene,
1,4-",Inhalation TC,"6.0E-02
mg/m3","Study Type: chronic
Species: male and female F344 rats
and BDF mice
1
Mode of Administration: inhalation
(whole body exposure chambers)
Exposure Regime: 1,4-dichlorobenzene
vapour at concentrations of 0, 20, 75, or
300 ppm (equivalent to 0, 120, 451,
and 1804 mg/m3) for 6 hours/day,
5 days/week
Duration: 104 weeks
Uncertainty Factors: 30 (3 for
intraspecies variability and 10 for
interspecies variability)","BMCL = 9.51 ppm
10
(57.2 mg/m3)","BMCL adjusted for
10
duration (1.70 ppm
[10.2 mg/m3])
+
Conversion to a BMCL
10_HEC
using a regional gas
deposition ratio
BMCL =
10_HEC
0.27 ppm (1.6 mg/m3)
TC = BMCL /UF
10_HEC","Respiratory
tract toxicity
(nasal lesions
[eosinophilic
changes in the
nasal olfactory
epithelium])",,"HC, 2018a
(based on ATSDR,
2006 [derived
from Aiso et al.,
2005 and JBRC,
1995])"
"Dichloroethane,
1,2- (DCA, 1,2-)",Oral SF,"3.3E-03
(mg/kg -day)â€“1
BW","Study Type: chronic
Species: male and female F344 rats
and BDF1 mice
Mode of Administration: inhalation
(whole body exposure chambers)
Exposure Regime: rats: 0, 10, 40, or
160 ppm 1,2-dichloroethane vapour (0,
202, 809 and 2024 mg/m3 or 0, 12, 50,
200 mg/kg ), 6 hours/day, 5 days/week;
BW
mice: 0, 10, 30, or 90 ppm
1,2-dichloroethane vapour (0, 40, 121,
364 mg/m3 or 0, 54, 162, 486 mg/kg ),
BW
6 hours/day, 5 days/week
Duration: 104 weeks
Uncertainty Factors: N/A","BMD of the 1,2-DCA
concentration rat
blood based on an
excess lifetime risk of
10-5
= 0.00027 mg/L","Rat PBPK model used to
extrapolate between
exposure routes (inhalation
to oral) and to estimate the
lifetime average daily
concentration in rat blood
+
Multistage modeling to
determine rat BMD
corresponding to an excess
lifetime risk of 10-5
+
PBPK model to extrapolate
from internal animal dose to
external dose in humans
(0.003 mg/kg -day)
BW
Oral SF =
10-5 / 0.003 mg/kg -day
BW","Cancer
(combined
mammary gland
tumours
[adenoma,
fibroadenoma, and
adenocarcinoma of
the mammary
gland])","CEPA: Group II
probably
carcinogenic
to humans
(EC and HC, 1994d)
IARC: Group 2B
possibly
carcinogenic
to humans
(IARC, 1999a)
US EPA IRIS:
Group B2
probably
carcinogenic
to humans
(US EPA, 1987b)","HC, 2014a
(based on
Nagano et al.,
2006)"
